Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
3
×
boston
clinical trials
fda
san francisco blog main
akouos
alex azar
alliance for aging research
amgen
andrew berens
astellas pharmaceuticals
avapritinib
biogen
biotech
biotechnology innovation organization
blueprint medicines
boston top stories
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer
deals
decibel therapeutics
deciphera pharmaceuticals
detroit blog main
detroit top stories
drug pricing
duane schulthess
eli lilly
erica whittaker
frequency therapeutics
gastrointestinal stromal tumor
gist
gleevec
harvard university
hearing loss
imatinib
indiana blog main
What
drug
3
×
plans
3
×
fda
administration
affects
americans
angry
announced
anti
approval
approved
benefited
blueprint
cancer
chasing
date
deadly
deciphera
despite
developing
fear
filing
forms
frequency
gi
hearing
industry
ipo
losing
loss
medicine
medicines
meds
millions
morning
pharamceuticals
pharma
presidential
price
regenerative
Language
unset
Current search:
plans
×
drug
×
" national blog main "
×
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans